Formycon

Valuation Analysis

About the Company

Formycon en bref

Formycon (FYB.DE) is currently trading at 19,60 € with a market capitalization of 302 M €. The 52-week range spans from 15,80 € to 31,30 €; the current price is 37.4% below the yearly high. Year-over-year revenue growth stands at +147.2%.

💰 Dividende

Formycon currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Avis des analystes

7 analystes évaluent Formycon (FYB.DE) au consensus : Acheter. L'objectif de cours moyen est de 39,86 €, soit un potentiel de +103.35% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 30,00 € à 53,00 €.

Formycon : la thèse d'investissement en détail

Formycon (FYB.DE) operates in the Healthcare — specifically Biotechnology — and is headquartered in Germany. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Top-line momentum is unusually strong with revenue expanding 147.2% year-over-year, a pace that puts the company well above the market average and signals genuine demand traction rather than mere cyclical tailwind. Wall Street consensus sits at Buy with an average price target implying roughly 103.35% upside from current levels — analyst sentiment is firmly constructive.

Le scénario baissier

Net margins remain negative, meaning every euro of revenue is still producing losses — the path to profitability is the central question for shareholders.

À surveiller

• The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
• The analyst consensus price target implies 103.35% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Aperçu technique

The price is in a transition zone relative to the moving averages — no clear signal.

Profil de risque

The data points to relatively defensive market behavior.

Trading Data

Related Stocks in the Same Sector

Where can I buy Formycon?

Compare top-rated brokers — low fees, trusted providers, fully regulated.